Skip to content

An Implementation Project to Improve Identification Of Altered Mood for People Hospitalised After Acute Stroke

Will patients with acute stroke who are admitted to a hospital providing the mood identification program have a greater likelihood of having altered mood identified than patients in hospitals providing standard care and when compared to an historical control period?

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614000839606
Acronym
IAMAS
Enrollment
200
Registered
2014-08-07
Start date
2014-05-19
Completion date
2015-12-24
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Altered mood is a common problem after stroke and can impact on stroke survivors’ recovery. Despite this it is often poorly identified by health professionals. Accessing psychology services after stroke is an enormous issue with only 12% of acute services having access to clinical psychology and 29% having protocols for referral to psychology. This pilot, implementation study aims to improve the identification of suspected altered mood in patients with stroke admitted to Hunter New England Health (HNEH) hub services. It will trial standardised processes and tools, supported by training for clinicians. Identification processes will commence early in the acute setting and continue during the stroke survivor's inpatient stay in HNEH hub facilities. Results from identifying suspected altered mood will be included in the patient discharge summary. This controlled, pre and post-implementation cohort design study will include comparisons to historical audit data and control sites.

Interventions

Patients with stroke and TIA admitted to intervention sites will be observed (from admission onwards) and screened (after 5 days) for altered mood. Screening will be undertaken using the Hospital Anxiety & Depression Scale (HADS) or for those with cognition/ communication issues the Behavioural Outcomes of Anxiety (BOA) and Stroke Aphasic Depression Questionnaire Hospital Version (SADQ-H10) tools. These will be repeated as clinically indicated. Staff will be trained in observation and screening.

Patients with stroke and TIA admitted to intervention sites will be observed (from admission onwards) and screened (after 5 days) for altered mood. Screening will be undertaken using the Hospital Anxiety & Depression Scale (HADS) or for those with cognition/ communication issues the Behavioural Outcomes of Anxiety (BOA) and Stroke Aphasic Depression Questionnaire Hospital Version (SADQ-H10) tools. These will be repeated as clinically indicated. Staff will be trained in observation and screening. Evidence of identification of altered mood, including screen scores, will be recorded in the medical record.

Sponsors

Hunter New England Local Health District
Lead SponsorGovernment body

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Diagnosis
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Admitted with clinical signs of stroke or Transient Ischaemic Attack (TIA) Participants located in a stroke unit or general ward

Exclusion criteria

nil

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026